Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas

por Martin-Castillo, Begoña, Lopez-Bonet, Eugeni, Cuyàs, Elisabet, Viñas, Gemma, Pernas, Sonia, Dorca, Joan, Menendez, Javier A.
Publicado 2015

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona

por Sanvisens, Arantza, Puigdemont, Montse, Rubió-Casadevall, Jordi, Vidal-Vila, Anna, López-Bonet, Eugeni, Martín-Romero, Ferran, Marcos-Gragera, Rafael
Publicado 2021

Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency

por Vazquez-Martin, Alejandro, Cufi, Sílvia, Lopez-Bonet, Eugeni, Corominas-Faja, Bruna, Oliveras-Ferraros, Cristina, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2012

Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer

por Martin-Castillo, Begoña, Lopez-Bonet, Eugeni, Buxó, Maria, Dorca, Joan, Tuca-Rodríguez, Francesc, Ruano, Miguel Alonso, Colomer, Ramon, Menendez, Javier A.
Publicado 2015

An improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients

por Ruano, Miguel Alonso, Lopez-Bonet, Eugeni, Buxó, Maria, Tuca-Rodríguez, Francesc, Vila-Camps, Ester, Alvarez, Elena, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2014

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

por Verdura, Sara, Cuyàs, Elisabet, Cortada, Eric, Brunet, Joan, Lopez-Bonet, Eugeni, Martin-Castillo, Begoña, Bosch-Barrera, Joaquim, Encinar, José Antonio, Menendez, Javier A.
Publicado 2020

Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: A case report and review of the literature

por ALONSO-RUANO, MIGUEL, LÓPEZ-BONET, EUGENI, HUERTA-ANAYA, MARIA VICTORIA, VILA-CAMPS, ESTER, BERNADÓ, LUIS, TUCA-RODRÍGUEZ, FRANCESC, SUAREZ-PUMARIEGA, PEDRO, MENENDEZ, JAVIER A.
Publicado 2013

The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer

por Cufí, Sílvia, Vazquez-Martin, Alejandro, Oliveras-Ferraros, Cristina, Corominas-Faja, Bruna, Cuyàs, Elisabet, López-Bonet, Eugeni, Martin-Castillo, Begoña, Joven, Jorge, Menendez, Javier A.
Publicado 2013

Prognostic significance of the microbiome–adipose tissue axis in rectal cancer: protocol of a prospective observational study

por Planellas, Pere, Cornejo, Lídia, Farrés, Ramon, Pigem, Anna, Timoteo, Ander, Ortega, Nuria, Pellino, Gianluca, Rodríguez-Hermosa, José-Ignacio, López-Bonet, Eugeni, Fernández-Real, José Manuel, Codina-Cazador, Antoni
Publicado 2022

Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate

por Vazquez-Martin, Alejandro, Van den Haute, Chris, Cufí, Sílvia, Corominas-Faja, Bruna, Cuyàs, Elisabet, Lopez-Bonet, Eugeni, Rodriguez-Gallego, Esther, Fernández-Arroyo, Salvador, Joven, Jorge, Baekelandt, Veerle, Menendez, Javier A.
Publicado 2016

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

por Bosch-Barrera, Joaquim, Verdura, Sara, Ruffinelli, José Carlos, Carcereny, Enric, Sais, Elia, Cuyàs, Elisabet, Palmero, Ramon, Lopez-Bonet, Eugeni, Hernández-Martínez, Alejandro, Oliveras, Gloria, Buxó, Maria, Izquierdo, Angel, Morán, Teresa, Nadal, Ernest, Menendez, Javier A.
Publicado 2021

Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin

por Cufí, Sílvia, Corominas-Faja, Bruna, Lopez-Bonet, Eugeni, Bonavia, Rosa, Pernas, Sonia, López, Isabel álvarez, Dorca, Joan, Martínez, Susana, López, Norberto Batista, Fernández, Severina Domínguez, Cuyàs, Elisabet, Visa, Joana, Rodríguez-Gallego, Esther, Quirantes-Piné, Rosa, Segura-Carretero, Antonio, Joven, Jorge, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2013

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics

por Puig-Costa, Manuel, Codina-Cazador, Antonio, Cortés-Pastoret, Elisabet, Oliveras-Ferraros, Cristina, Cufí, Sílvia, Flaquer, Sílvia, Llopis-Puigmarti, Francesca, Pujol-Amado, Eulalia, Corominas-Faja, Bruna, Cuyàs, Elisabet, Ortiz, Rosa, Lopez-Bonet, Eugeni, Queralt, Bernardo, Guardeño, Raquel, Martin-Castillo, Begoña, Roig, Josep, Joven, Jorge, Menendez, Javier A.
Publicado 2014

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals—Planification, Implementation, and Preliminary Results

por Temprana-Salvador, Jordi, López-García, Pablo, Castellví Vives, Josep, de Haro, Lluís, Ballesta, Eudald, Rojas Abusleme, Matias, Arrufat, Miquel, Marques, Ferran, Casas, Josep R., Gallego, Carlos, Pons, Laura, Mate, José Luis, Fernández, Pedro Luis, López-Bonet, Eugeni, Bosch, Ramon, Martínez, Salomé, Ramón y Cajal, Santiago, Matias-Guiu, Xavier
Publicado 2022

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

por Cuyàs, Elisabet, Fernández-Arroyo, Salvador, Buxó, Maria, Pernas, Sonia, Dorca, Joan, Álvarez, Isabel, Martínez, Susana, Pérez-Garcia, Jose Manuel, Batista-López, Norberto, Rodríguez-Sánchez, César A., Amillano, Kepa, Domínguez, Severina, Luque, Maria, Morilla, Idoia, Stradella, Agostina, Viñas, Gemma, Cortés, Javier, Verdura, Sara, Brunet, Joan, López-Bonet, Eugeni, Garcia, Margarita, Saidani, Samiha, Joven, Jorge, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2019

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

por Cuyàs, Elisabet, Buxó, Maria, Ferri Iglesias, Maria José, Verdura, Sara, Pernas, Sonia, Dorca, Joan, Álvarez, Isabel, Martínez, Susana, Pérez-Garcia, Jose Manuel, Batista-López, Norberto, Rodríguez-Sánchez, César A., Amillano, Kepa, Domínguez, Severina, Luque, Maria, Morilla, Idoia, Stradella, Agostina, Viñas, Gemma, Cortés, Javier, Joven, Jorge, Brunet, Joan, López-Bonet, Eugeni, Garcia, Margarita, Saidani, Samiha, Queralt Moles, Xavier, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2019

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

por Lopez-Bonet, Eugeni, Buxó, Maria, Cuyàs, Elisabet, Pernas, Sonia, Dorca, Joan, Álvarez, Isabel, Martínez, Susana, Pérez-Garcia, Jose Manuel, Batista-López, Norberto, Rodríguez-Sánchez, César A., Amillano, Kepa, Domínguez, Severina, Luque, Maria, Morilla, Idoia, Stradella, Agostina, Viñas, Gemma, Cortés, Javier, Oliveras, Gloria, Meléndez, Cristina, Castillo, Laura, Verdura, Sara, Brunet, Joan, Joven, Jorge, Garcia, Margarita, Saidani, Samiha, Martin-Castillo, Begoña, Menendez, Javier A.
Publicado 2019

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

por Martin-Castillo, Begoña, Pernas, Sonia, Dorca, Joan, Álvarez, Isabel, Martínez, Susana, Pérez-Garcia, Jose Manuel, Batista-López, Norberto, Rodríguez-Sánchez, César A., Amillano, Kepa, Domínguez, Severina, Luque, Maria, Stradella, Agostina, Morilla, Idoia, Viñas, Gemma, Cortés, Javier, Cuyàs, Elisabet, Verdura, Sara, Fernández-Ochoa, Álvaro, Fernández-Arroyo, Salvador, Segura-Carretero, Antonio, Joven, Jorge, Pérez, Elsa, Bosch, Neus, Garcia, Margarita, López-Bonet, Eugeni, Saidani, Samiha, Buxó, Maria, Menendez, Javier A.
Publicado 2018